Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.05
Delayed Data
As of Jul 31
 -0.06 / -2.84%
Today’s Change
1.83
Today|||52-Week Range
5.48
-57.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues14.7M32.7M5.0M9.0M
 
 
 
 
 
Cost of Goods Sold419.4K427.0K392.7K1.5M
 
 
 
 
 
Depreciation And Amortization1.5M1.5M1.0M569.4K
 
 
 
 
 
 
Operating ExpensesGross Income12.8M30.8M3.5M6.9M
 
 
 
 
 
General Expenses31.8M29.9M35.1M42.5M
 
 
 
 
 
Research And Development25.4M24.8M29.2M33.1M
 
 
 
 
 
Total Operating Expenses33.7M31.9M36.5M44.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.0M874.2K-31.6M-35.6M
 
 
 
 
 
Extraordinary Credit2.9M0.0016.7M0.00
 
 
 
Other Expenses480.4K32.0K2.6M938.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.1M906.2K-12.2M-35.5M
 
 
 
 
 
Income Taxes-109.9K-209.8K-44.1K-7.8K
 
 
 
 
 
Minority Interest-174.0K-113.6K-104.8K-105.4K
 
 
 
 
 
Net Income-15.1M810.0K-12.2M-35.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS75.3M75.5M78.0M84.6M
 
 
 
 
 
Shares To Calculate EPS Diluted75.3M76.2M78.0M84.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20$0.01-$0.16-$0.42
 
 
 
 
 
EPS Diluted-$0.20$0.01-$0.16-$0.42